Alaska Air Group ALK is gaining from an uptick in air-travel demand (particularly on the leisure front). The upsurge in ...

On May 3, Alk-Abello A-S Bearer and-or registered B will release figures for Q1. 3 analysts are estimating earnings of DKK 0.977 per share compared to earnings of DKK 0.740 per share in the same ...

The company reported revenue of $2.23 billion and an adjusted loss per share of $0.92, compared to the consensus estimates of ...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the 2024 full-year financial outlook has been updated. Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The economy continues to give investors mixed signals.

On 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib), an oral anaplastic ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Investors with an interest in Transportation - Airline stocks have likely encountered both Alaska Air Group (ALK) and Ryanair (RYAAY). But which of these two companies is the best option for those ...

The US Food and Drug Administration (FDA) has approved alectinib (Alecensa, Genentech) in the adjuvant setting following ...

Due to its increased sensitivity and capacity to identify mutations with low allele frequency, next-generation sequencing ...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the 2024 full-year financial outlook has been updated. Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The ...